2007
DOI: 10.1021/nn7002025
|View full text |Cite
|
Sign up to set email alerts
|

Multiple Lipid Compartments Slow Vesicle Contents Release in Lipases and Serum

Abstract: Unilamellar vesicles or "liposomes" are commonly used as simple cell models and as drug delivery vehicles. A major limitation of unilamellar liposomes in these applications has been premature contents release in physiological environments. This premature release is likely due to enzyme degradation or protein insertion into the liposome membrane, which significantly increases the bilayer permeability. Encapsulating unilamellar liposomes within a second bilayer to form multicompartment "vesosomes" extends conten… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
128
0
1

Year Published

2010
2010
2020
2020

Publication Types

Select...
9
1

Relationship

1
9

Authors

Journals

citations
Cited by 125 publications
(129 citation statements)
references
References 34 publications
0
128
0
1
Order By: Relevance
“…[1][2][3][4][5][6][7][8][9][10][11][12][13][14][15][16][17] The investigations, by means of time-resolved SAXS, of the dynamic topological transitions of selfassembled amphiphilic mixtures have allowed the discovery of lipid-based nanocarriers with tunable internal organizations and nanochannel sizes. [18][19][20][21][22][23][24][25][26][27][28][29][30][31][32] The phase states of nonlamellar lipids, amphiphilic mixtures with lipopolymers or lipophilic conjugates, such as peptide surfactants, squalenoyl (SQ) derivatives, and acylated and peptidolipidyl-modified cyclodextrins, have been studied toward the design of novel controlled drug delivery nanocarriers with enhanced performance.…”
Section: Introductionmentioning
confidence: 99%
“…[1][2][3][4][5][6][7][8][9][10][11][12][13][14][15][16][17] The investigations, by means of time-resolved SAXS, of the dynamic topological transitions of selfassembled amphiphilic mixtures have allowed the discovery of lipid-based nanocarriers with tunable internal organizations and nanochannel sizes. [18][19][20][21][22][23][24][25][26][27][28][29][30][31][32] The phase states of nonlamellar lipids, amphiphilic mixtures with lipopolymers or lipophilic conjugates, such as peptide surfactants, squalenoyl (SQ) derivatives, and acylated and peptidolipidyl-modified cyclodextrins, have been studied toward the design of novel controlled drug delivery nanocarriers with enhanced performance.…”
Section: Introductionmentioning
confidence: 99%
“…These include careful assembly protocols for encapsulation of smaller vesicles within larger ones to create multicompartmental vesosomes [17][18][19], within layer-by-layer polymer shells [20][21][22], encapsulation of aqueous two phase systems within single liposomes [23][24][25] and association of lipid vesicles via site-specific ligand-receptor interactions such as biotin-avidin bonds [26][27][28]. Many of these approaches were discussed in a recent review [29].…”
mentioning
confidence: 99%
“…Liposomes formulated in the presence of aqueous PBS instead of ABC were used as the control (Lip-PBS). Using the method of phospholipid hydration followed by sequential extrusion and dialysis, 15 it was not difficult to incorporate ABC solution into liposomes, measure the diameter with a liposome extrusion apparatus, and remove the excess ABC solution with dialysate. Both Lip-ABC and Lip-PBS had nanoscale particle diameters and good uniformity (Table 1; Figure 1A and B) and would be able to pass through the tumor vascular endothelial space.…”
Section: Results and Discussion Lip-abc Preparation And Characteristicsmentioning
confidence: 99%